Johnson & Johnson vs. Omeros Corporation
Johnson & Johnson (JNJ) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| JNJ | OMER | |
|---|---|---|
| Market Cap | $658.89 billion | $1.33 billion |
| Revenue (TTM) | $97.93 billion | $38.42 million |
| Net Income (TTM) | $21.04 billion | $124.83 million |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | OMER | |
|---|---|---|
| P/E Ratio | 31.50 | 11.21 |
| Price / Book | 7.75 | -25.92 |
| Price / Sales | 6.73 | 34.65 |
OMER leads on 2 of 3 valuation factors.
Profitability
| JNJ | OMER | |
|---|---|---|
| Net Margin | 21.48% | 324.88% |
| Return on Equity | 24.76% | -243.09% |
JNJ and OMER split the profitability factors evenly.
Dividend
| JNJ | OMER | |
|---|---|---|
| Dividend Yield | 1.97% | — |
| Payout Ratio | 62.18 | — |
JNJ and OMER split the dividend factors evenly.
Risk & Sentiment
| JNJ | OMER | |
|---|---|---|
| Short Interest | 0.67% | 9.61% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, OMER overview, OMER financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.